MedTrace Logo

The Effect of Malaria on Disease Progression of HIV/AIDS

NCT00499876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this study is to find out whether malaria affects how HIV/AIDS disease progresses in an infected patient, and to determine the effect of reducing malaria infection on HIV disease progression in Kumasi

Conditions

Interventions

DRUG

mefloquine

250mg weekly PO for 6 months

OTHER

placebo

1 tablet weekly PO for 6 months

Sponsors & Collaborators

  • Noguchi Memorial Institute for Medical Research

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Ruby Martin-Peprah, MBChB, PhD · Komfo Anokye Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-10-31
Completion
2009-12-31

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00499876 on ClinicalTrials.gov